Cargando…

Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis: an exploratory study

INTRODUCTION: Quinolone prophylaxis is recommended for patients with advanced cirrhosis at high risk of spontaneous bacterial peritonitis (SBP) or with prior SBP. Yet, the impact of long-term antibiotic prophylaxis on the microbiome of these patients is poorly characterized. METHODS: Patients with l...

Descripción completa

Detalles Bibliográficos
Autores principales: Mücke, Marcus M., Rüschenbaum, Sabrina, Mayer, Amelie, Mücke, Victoria T., Schwarzkopf, Katharina M., Zeuzem, Stefan, Kehrmann, Jan, Scholtysik, René, Lange, Christian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596951/
https://www.ncbi.nlm.nih.gov/pubmed/33133240
http://dx.doi.org/10.1186/s13099-020-00389-y
_version_ 1783602224063053824
author Mücke, Marcus M.
Rüschenbaum, Sabrina
Mayer, Amelie
Mücke, Victoria T.
Schwarzkopf, Katharina M.
Zeuzem, Stefan
Kehrmann, Jan
Scholtysik, René
Lange, Christian M.
author_facet Mücke, Marcus M.
Rüschenbaum, Sabrina
Mayer, Amelie
Mücke, Victoria T.
Schwarzkopf, Katharina M.
Zeuzem, Stefan
Kehrmann, Jan
Scholtysik, René
Lange, Christian M.
author_sort Mücke, Marcus M.
collection PubMed
description INTRODUCTION: Quinolone prophylaxis is recommended for patients with advanced cirrhosis at high risk of spontaneous bacterial peritonitis (SBP) or with prior SBP. Yet, the impact of long-term antibiotic prophylaxis on the microbiome of these patients is poorly characterized. METHODS: Patients with liver cirrhosis receiving long-term quinolone prophylaxis to prevent SBP were prospectively included and sputum and stool samples were obtained at baseline, 1, 4 and 12 weeks thereafter. Both bacterial DNA and RNA were assessed with 16S rRNA sequencing. Relative abundance, alpha and beta diversity were calculated and correlated with clinical outcome. RESULTS: Overall, 35 stool and 19 sputum samples were obtained from 11 patients. Two patients died (day 9 and 12) all others were followed for 180 days. Reduction of Shannon diversity and bacterial richness was insignificant after initiation of quinolone prophylaxis (p > 0.05). Gut microbiota were significantly different between patients (p < 0.001) but non-significantly altered between the different time points before and after initiation of antibiotic prophylaxis (p > 0.05). A high relative abundance of Enterobacteriaceae > 20% during quinolone prophylaxis was found in three patients. Specific clinical scenarios (development of secondary infections during antibiotic prophylaxis or the detection of multidrug-resistant Enterobacteriaceae) characterized these patients. Sputum microbiota were not significantly altered in individuals during prophylaxis. CONCLUSION: The present exploratory study with small sample size showed that inter-individual differences in diversity of gut microbiota were high at baseline, yet quinolone prophylaxis had only a moderate impact. High relative abundances of Enterobacteriaceae during follow-up might indicate failure of or non-adherence to quinolone prophylaxis. However, our results may not be clinically significant given the limitations of the study and therefore future studies are needed to further investigate this phenomenon.
format Online
Article
Text
id pubmed-7596951
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75969512020-10-30 Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis: an exploratory study Mücke, Marcus M. Rüschenbaum, Sabrina Mayer, Amelie Mücke, Victoria T. Schwarzkopf, Katharina M. Zeuzem, Stefan Kehrmann, Jan Scholtysik, René Lange, Christian M. Gut Pathog Research INTRODUCTION: Quinolone prophylaxis is recommended for patients with advanced cirrhosis at high risk of spontaneous bacterial peritonitis (SBP) or with prior SBP. Yet, the impact of long-term antibiotic prophylaxis on the microbiome of these patients is poorly characterized. METHODS: Patients with liver cirrhosis receiving long-term quinolone prophylaxis to prevent SBP were prospectively included and sputum and stool samples were obtained at baseline, 1, 4 and 12 weeks thereafter. Both bacterial DNA and RNA were assessed with 16S rRNA sequencing. Relative abundance, alpha and beta diversity were calculated and correlated with clinical outcome. RESULTS: Overall, 35 stool and 19 sputum samples were obtained from 11 patients. Two patients died (day 9 and 12) all others were followed for 180 days. Reduction of Shannon diversity and bacterial richness was insignificant after initiation of quinolone prophylaxis (p > 0.05). Gut microbiota were significantly different between patients (p < 0.001) but non-significantly altered between the different time points before and after initiation of antibiotic prophylaxis (p > 0.05). A high relative abundance of Enterobacteriaceae > 20% during quinolone prophylaxis was found in three patients. Specific clinical scenarios (development of secondary infections during antibiotic prophylaxis or the detection of multidrug-resistant Enterobacteriaceae) characterized these patients. Sputum microbiota were not significantly altered in individuals during prophylaxis. CONCLUSION: The present exploratory study with small sample size showed that inter-individual differences in diversity of gut microbiota were high at baseline, yet quinolone prophylaxis had only a moderate impact. High relative abundances of Enterobacteriaceae during follow-up might indicate failure of or non-adherence to quinolone prophylaxis. However, our results may not be clinically significant given the limitations of the study and therefore future studies are needed to further investigate this phenomenon. BioMed Central 2020-10-30 /pmc/articles/PMC7596951/ /pubmed/33133240 http://dx.doi.org/10.1186/s13099-020-00389-y Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Mücke, Marcus M.
Rüschenbaum, Sabrina
Mayer, Amelie
Mücke, Victoria T.
Schwarzkopf, Katharina M.
Zeuzem, Stefan
Kehrmann, Jan
Scholtysik, René
Lange, Christian M.
Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis: an exploratory study
title Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis: an exploratory study
title_full Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis: an exploratory study
title_fullStr Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis: an exploratory study
title_full_unstemmed Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis: an exploratory study
title_short Stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis: an exploratory study
title_sort stool and sputum microbiome during quinolone prophylaxis of spontaneous bacterial peritonitis: an exploratory study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596951/
https://www.ncbi.nlm.nih.gov/pubmed/33133240
http://dx.doi.org/10.1186/s13099-020-00389-y
work_keys_str_mv AT muckemarcusm stoolandsputummicrobiomeduringquinoloneprophylaxisofspontaneousbacterialperitonitisanexploratorystudy
AT ruschenbaumsabrina stoolandsputummicrobiomeduringquinoloneprophylaxisofspontaneousbacterialperitonitisanexploratorystudy
AT mayeramelie stoolandsputummicrobiomeduringquinoloneprophylaxisofspontaneousbacterialperitonitisanexploratorystudy
AT muckevictoriat stoolandsputummicrobiomeduringquinoloneprophylaxisofspontaneousbacterialperitonitisanexploratorystudy
AT schwarzkopfkatharinam stoolandsputummicrobiomeduringquinoloneprophylaxisofspontaneousbacterialperitonitisanexploratorystudy
AT zeuzemstefan stoolandsputummicrobiomeduringquinoloneprophylaxisofspontaneousbacterialperitonitisanexploratorystudy
AT kehrmannjan stoolandsputummicrobiomeduringquinoloneprophylaxisofspontaneousbacterialperitonitisanexploratorystudy
AT scholtysikrene stoolandsputummicrobiomeduringquinoloneprophylaxisofspontaneousbacterialperitonitisanexploratorystudy
AT langechristianm stoolandsputummicrobiomeduringquinoloneprophylaxisofspontaneousbacterialperitonitisanexploratorystudy